Post by Biospring Partners

We’re excited to share an upcoming webinar featuring our portfolio companies Cellistic and Ncardia, exploring the critical role of iPSCs in advancing cell therapy and drug discovery. Cellistic and Ncardia are at the forefront of the growing demand for iPSC-based applications, from allogeneic cell therapies to human-relevant translational models. Leadership will discuss how their proprietary manufacturing platforms and service offerings are helping accelerate development timelines for pharma and biotech partners. We’ll also cover recent global developments in the iPSC space, including landmark approvals and evolving policy frameworks. The session will be moderated by Socrates Zacharias, Principal at Biospring. Register here: https://lnkd.in/dEM_PDzh